Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fleseriu

Showing results (151-160 of 268) with videos related to

Pageof 27
Sort By:
Pituitary|December 27, 2024
Can we predict the risk of venous thromboembolism in patients with Cushing's syndrome: a nationwide cohort analysisYaron Rudman, Michal Michaelis, Ilan Shimon, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 11, 2008
Cushing's syndrome might be underappreciated in patients seeking bariatric surgery: a plea for screeningMaria Fleseriu, William H Ludlam, Swee H Teh, et al.
Operative Neurosurgery (Hagerstown, Md.)|February 4, 2026
Cavernous Sinus Medial Wall Resection: A Retrospective Single-Institution Study on Outcomes in Functional Pituitary AdenomasOlabisi R Sanusi, Eniola Otukoya, Saud Zaidan, et al.
The Lancet. Diabetes & Endocrinology|April 17, 2015
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort studyDaojun Mo, Maria Fleseriu, Rong Qi, et al.
Pituitary|October 26, 2010
Temozolomide for corticotroph pituitary adenomas refractory to standard therapyTroy H Dillard, S Humayun Gultekin, Johnny B Delashaw, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristoneMaria Fleseriu, Mark E Molitch, Coleman Gross, et al.
Endocrine-Related Cancer|June 9, 2025
Predictors of cancer in patients with endogenous Cushing's syndromeYaron Rudman, Genady Drozdinsky, Hiba Masri-Iraqi, et al.
Pituitary|March 12, 2013
Absence of immunostaining for growth hormone in a subset of patients with acromegalyJason L Schroeder, Alejandro M Spiotta, Maria Fleseriu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2012
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndromeMaria Fleseriu, Beverly M K Biller, James W Findling, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2016
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice GuidelineMaria Fleseriu, Ibrahim A Hashim, Niki Karavitaki, et al.
Pageof 27

Showing results (151-160 of 268) with videos related to

Sort By:
Pageof 27
Pituitary|December 27, 2024
Can we predict the risk of venous thromboembolism in patients with Cushing's syndrome: a nationwide cohort analysisYaron Rudman, Michal Michaelis, Ilan Shimon, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 11, 2008
Cushing's syndrome might be underappreciated in patients seeking bariatric surgery: a plea for screeningMaria Fleseriu, William H Ludlam, Swee H Teh, et al.
Operative Neurosurgery (Hagerstown, Md.)|February 4, 2026
Cavernous Sinus Medial Wall Resection: A Retrospective Single-Institution Study on Outcomes in Functional Pituitary AdenomasOlabisi R Sanusi, Eniola Otukoya, Saud Zaidan, et al.
The Lancet. Diabetes & Endocrinology|April 17, 2015
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort studyDaojun Mo, Maria Fleseriu, Rong Qi, et al.
Pituitary|October 26, 2010
Temozolomide for corticotroph pituitary adenomas refractory to standard therapyTroy H Dillard, S Humayun Gultekin, Johnny B Delashaw, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristoneMaria Fleseriu, Mark E Molitch, Coleman Gross, et al.
Endocrine-Related Cancer|June 9, 2025
Predictors of cancer in patients with endogenous Cushing's syndromeYaron Rudman, Genady Drozdinsky, Hiba Masri-Iraqi, et al.
Pituitary|March 12, 2013
Absence of immunostaining for growth hormone in a subset of patients with acromegalyJason L Schroeder, Alejandro M Spiotta, Maria Fleseriu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2012
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndromeMaria Fleseriu, Beverly M K Biller, James W Findling, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2016
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice GuidelineMaria Fleseriu, Ibrahim A Hashim, Niki Karavitaki, et al.
Pageof 27